Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads
to difficulties with movement and, eventually, to the need for assisted ventilation and …

Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease
of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy. The identification …

Summary Background Cardiosphere-derived cells (CDCs) ameliorate skeletal and cardiac
muscle deterioration in experimental models of Duchenne muscular dystrophy. The HOPE-2 …

Duchenne muscular dystrophy (DMD) is a severe, progressive, and incurable X-linked
disorder caused by mutations in the dystrophin gene. Patients with DMD have an absence of …

The mainstay of treatment remains meeting well defined standards of care that have been
shown to influence morbidity and mortality. These include use of systemic steroids, early …

Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disorder that
causes debilitating muscle weakness and atrophy due to a loss of the dystrophin protein …

Duchenne muscular dystrophy (DMD) afflicts 1 in 5000 newborn males, leading to
progressive muscle weakening and the loss of ambulation between the ages of 8 and 12 …

Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by
mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of …

This scientific statement from the American Heart Association focuses on treatment
strategies and modalities for cardiomyopathy (heart muscle disease) in children and serves …

Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder with increasing
life expectancy from late teens to over 30 years of age. The aim of this nationwide study was …